Seasonal Variation of Glucose Variability in Rather Elderly Patients with Type 2 Diabetes (T2D) Treated by Vildagliptin and Metformin (EquMet)

Asploro journal of biomedical and clinical case reports Pub Date : 2022-10-22 DOI:10.36502/2022/asjbccr.6278

H. Bando, H. Yamashita, Y. Kato, T. Kawata, Y. Kato, H. Kanagawa

引用次数: 5

Abstract

Background: Seasonal variation of HbA1c has been in focus. Patients and Methods: The protocol included type 2 diabetes (T2D) patients (n=26, 71.4±10.2 years) on vildagliptin and metformin (EquMet) and HbA1c changes in 4 seasons for 6 years. Results: HbA1c values ranged 6.9-7.5%, and tend to show highest in winter, and rather lower in autumn. Discussion & Conclusion: Rather elderly T2D cases can tolerate EquMet with fair control. Previous reports showed a similar tendency. Some factors may be involved in the variation, such as temperature, climate, carbohydrate intake, Ramadan, and others. Furthermore, blood pressure and cardiovascular disease (CVD) can also influence them.

查看原文本刊更多论文

维达格利汀和二甲双胍（EquMet）治疗老年2型糖尿病（T2D）患者血糖变异性的季节变化

背景：HbA1c的季节性变化一直是人们关注的焦点。患者和方法：该方案包括2型糖尿病（T2D）患者（n=26，71.4±10.2岁）服用维达格利汀和二甲双胍（EquMet），4个季节的HbA1c变化持续6年。结果：HbA1c值范围为6.9-7.5%，冬季最高，秋季较低。讨论与结论：老年T2D患者可以耐受EquMet，并有公平的控制。以前的报告显示了类似的趋势。一些因素可能与变化有关，如温度、气候、碳水化合物摄入、斋月等。此外，血压和心血管疾病（CVD）也会影响它们。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Asploro journal of biomedical and clinical case reports

自引率

0.00%

发文量